Abeona Therapeutics Inc.
ABEO
$6.83
-$0.05-0.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 400.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 400.00K | -- | -- | -- | -- |
| Cost of Revenue | 6.04M | 9.94M | 33.31M | 485.00K | 9.22M |
| Gross Profit | -5.64M | -9.94M | -33.31M | -485.00K | -9.22M |
| SG&A Expenses | 17.15M | 9.79M | 7.68M | 6.40M | 8.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.19M | 19.73M | 16.67M | 15.35M | 17.86M |
| Operating Income | -22.79M | -19.73M | -16.67M | -15.35M | -17.86M |
| Income Before Tax | 124.35M | -12.03M | -9.29M | -30.27M | 7.41M |
| Income Tax Expenses | 15.51M | -- | -- | -- | -- |
| Earnings from Continuing Operations | 108.83M | -12.03M | -9.29M | -30.27M | 7.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 108.83M | -12.03M | -9.29M | -30.27M | 7.41M |
| EBIT | -22.79M | -19.73M | -16.67M | -15.35M | -17.86M |
| EBITDA | -22.25M | -19.19M | -16.13M | -14.86M | -17.38M |
| EPS Basic | 2.07 | -0.24 | -0.19 | -0.63 | 0.19 |
| Normalized Basic EPS | -0.33 | -0.15 | -0.12 | -0.39 | 0.12 |
| EPS Diluted | 1.71 | -0.24 | -0.19 | -0.63 | -0.26 |
| Normalized Diluted EPS | -0.26 | -0.15 | -0.12 | -0.39 | 0.09 |
| Average Basic Shares Outstanding | 52.52M | 49.78M | 48.68M | 48.08M | 40.01M |
| Average Diluted Shares Outstanding | 66.64M | 49.78M | 48.68M | 48.08M | 51.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |